Back to mobile site

More on ODTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:ODTX)
Delayed: 20.51 +0.58 (2.91%)
Prev. Close $19.93  
Open$19.90 
52 Wk High$ 
52 Wk Low$ 
Day High$20.88 
Day Low$19.41 
P/E N/A  
EPS$ 
Volume237,781 

Friends, Peers and Foes (?): EVO EVT (more...)

Sep 16, 2026 08:00 AM Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
Aug 27, 2026 06:04 AM H.C. Wainwright Starts Odyssey Therapeutics (ODTX) at Buy
Aug 26, 2026 08:00 AM Odyssey Therapeutics to Participate in Upcoming Investor Conferences
Aug 7, 2026 09:09 AM Odyssey Therapeutics (ODTX) PT Raised to $29 at JPMorgan
Aug 6, 2026 06:05 AM Form 10-Q Odyssey Therapeutics, For: Jun 30
Aug 6, 2026 06:00 AM Evotec and Odyssey partner on autoimmune drug discovery
Aug 6, 2026 02:17 AM Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
Aug 4, 2026 07:00 AM Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Jun 17, 2026 04:15 PM Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Jun 2, 2026 06:59 AM Wedbush Starts Odyssey Therapeutics (ODTX) at Outperform
View All Articles

Entities mentioned with ODTX

View All Entities